CRMD EBITDA | CORMEDIX INC.

CORMEDIX INC. (CRMD) EBITDA

2026-06-30: Basis Reported; EBITDA $53.45M*; Operating income $42.91M; Depreciation and amortization $10.54M*.
2026-03-31: Basis Reported; EBITDA $74.2M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income $51.35M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA $19.71M*; Operating income $19.54M; Depreciation and amortization $163.00K*.

Complete source-backed ebitda history.

Available history: 2025-03-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$53.45M*	$42.91M	$10.54M*	$101.93M	52.44%*	$561.00K*	$86.24M*	(m)	$6.68M	(m)	$12.74M
2026-03-31	Reported	$74.2M	(m)	(m)	(m)	(m)	$729.00K	$42.38M	(m)	$7.21M	(m)	$17.04M
2025-09-30	Reported	(m)	$51.35M	(m)	(m)	(m)	$505.90K*	$30.86M*	(m)	$5.10M	(m)	-$55.99M
2025-06-30	Reported	$19.71M*	$19.54M	$163.00K*	$39.74M	49.59%*	$24.00K*	$29.99M*	(m)	$2.44M	(m)	$522.00K
2025-03-31	Reported	$20.29M	(m)	(m)	(m)	(m)	$10.00K	$19.74M	(m)	$3.19M	(m)	$0.00
2024-09-30	Reported	(m)	-$3.29M	(m)	(m)	(m)	$9.77K*	-$13.65M*	(m)	$727.12K	(m)	$0.00*
2024-06-30	Reported	(m)	-$15.30M	(m)	(m)	(m)	$34.79K*	-$14.04M*	(m)	$650.99K	(m)	$0.00*
2024-03-31	Reported	(m)	-$16.70M	(m)	(m)	(m)	$61.31K	-$17.31M	(m)	$837.45K	$15.05M	-$1.39M
2023-09-30	Reported	(m)	-$10.47M	(m)	(m)	(m)	$10.24K*	-$8.70M*	(m)	$2.66M	$7.80M	(m)
2023-06-30	Reported	(m)	-$11.80M	(m)	(m)	(m)	$6.36K*	-$8.57M*	(m)	$4.79M	$7.01M	(m)
2023-03-31	Reported	(m)	-$11.02M	(m)	(m)	(m)	$14.77K	-$10.39M	(m)	$3.41M	$7.61M	(m)
2022-09-30	Reported	(m)	-$6.96M	(m)	(m)	(m)	$76.42K*	-$6.00M*	(m)	$2.34M	$4.63M	$0.00*
2022-06-30	Reported	(m)	-$8.24M	(m)	(m)	(m)	$9.86K*	-$5.46M*	(m)	$3.21M	$5.05M	-$585.62K
2022-03-31	Reported	(m)	-$7.03M	(m)	(m)	(m)	$4.32K	-$6.74M	(m)	$2.29M	$4.75M	(m)
2021-09-30	Reported	(m)	-$8.56M	(m)	(m)	(m)	$777.87K*	-$5.50M*	(m)	$4.74M	$3.84M	$0.00*
2021-06-30	Reported	(m)	-$5.88M	(m)	(m)	(m)	$5.62K*	-$3.09M*	(m)	$2.52M	$3.36M	-$1.25M
2021-03-31	Reported	(m)	-$7.21M	(m)	(m)	(m)	$13.08K	-$6.69M	(m)	$2.64M	$4.60M	(m)
2020-09-30	Reported	(m)	-$6.60M	(m)	(m)	(m)	$21.60K*	-$7.31M*	(m)	$2.93M	$3.69M	$0.00*
2020-06-30	Reported	(m)	-$8.92M	(m)	(m)	(m)	$4.04K*	-$754.37K*	(m)	$5.69M	$3.23M	-$5.17M
2020-03-31	Reported	(m)	-$5.61M	(m)	(m)	(m)	$9.92K	-$7.97M	(m)	$2.47M	$3.17M	(m)
2019-09-30	Reported	(m)	-$5.17M	(m)	(m)	(m)	$4.42K*	-$3.96M*	(m)	$2.52M	$2.63M	$0.00*
2019-06-30	Reported	(m)	-$5.54M	(m)	(m)	(m)	$3.51K*	$164.46K*	(m)	$2.98M	$2.57M	-$5.06M
2019-03-31	Reported	(m)	-$4.92M	(m)	(m)	(m)	$19.22K	-$7.37M	(m)	$2.87M	$1.98M	(m)
2018-09-30	Reported	(m)	-$10.24M	(m)	(m)	(m)	$10.67K*	-$5.11M*	(m)	$8.29M	$2.01M	(m)
2018-06-30	Reported	(m)	-$8.57M	(m)	(m)	(m)	-$1.00*	-$4.34M*	(m)	$6.60M	$1.95M	$0.00
2018-03-31	Reported	(m)	-$10.19M	(m)	(m)	(m)	$38.23K	-$7.05M	(m)	$8.28M	$1.90M	(m)
2017-09-30	Reported	(m)	-$8.01M	(m)	(m)	(m)	$22.71K*	-$6.80M*	(m)	$6.01M	$1.99M	(m)
2017-06-30	Reported	(m)	-$7.02M	(m)	(m)	(m)	$1.92K*	-$7.75M*	(m)	$5.09M	$2.05M	(m)
2017-03-31	Reported	(m)	-$7.62M	(m)	(m)	(m)	$2.00K	-$6.76M	(m)	$4.92M	$2.64M	(m)
2016-12-31	Reported	(m)	-$6.43K	(m)	(m)	(m)	(m)	(m)	(m)	$4.03K	(m)	(m)
2016-09-30	Reported	(m)	-$9.16M	(m)	(m)	(m)	$53.16K*	-$6.55M*	(m)	$6.84M	$2.32M	(m)
2016-06-30	Reported	(m)	-$4.91M	(m)	(m)	(m)	$1.94K*	-$3.77M*	(m)	$2.77M	$1.97M	(m)
2016-03-31	Reported	(m)	-$4.15M	(m)	(m)	(m)	$0.00	-$5.45M	(m)	$2.09M	$2.05M	(m)
2015-12-31	Reported	(m)	-$3.89K	(m)	(m)	(m)	(m)	(m)	(m)	$1.49K	(m)	(m)
2015-09-30	Reported	(m)	-$4.71K	(m)	(m)	(m)	-$1.00*	-$2.94M*	(m)	$1.76K	$2.95M	(m)
2015-06-30	Reported	(m)	-$4.13K	(m)	(m)	(m)	$853.00*	-$3.60M*	(m)	$1.80K	$2.36M	(m)
2015-03-31	Reported	(m)	-$3.91K	(m)	(m)	(m)	$12.94K	-$2.35M	(m)	$1.24K	$2.69M	(m)
2014-09-30	Reported	(m)	-$1.86M	(m)	(m)	(m)	$6.29K*	-$1.81M*	(m)	$292.69K	$1.59M	(m)
2014-06-30	Reported	(m)	-$1.89M	(m)	(m)	(m)	$19.61K*	-$1.51M*	(m)	$171.93K	$1.70M	(m)
2014-03-31	Reported	(m)	-$2.93M	(m)	(m)	(m)	$0.00	-$1.43M	(m)	$353.02K	$2.51M	$0.00
2013-09-30	Reported	(m)	-$1.26M	(m)	(m)	(m)	$0.00*	-$1.52M*	(m)	$750.77K	$504.53K	$0.00
2013-06-30	Reported	(m)	-$1.29M	(m)	(m)	(m)	$0.00*	-$559.32K*	(m)	$380.17K	$908.74K	$0.00
2013-03-31	Reported	(m)	-$806.78K	(m)	(m)	(m)	$0.00	-$617.75K	(m)	$255.03K	$551.74K	$0.00
2012-09-30	Reported	(m)	-$991.14K	(m)	(m)	(m)	$0.00*	-$671.60K*	(m)	$244.49K	(m)	$0.00
2012-06-30	Reported	(m)	-$613.56K	(m)	(m)	(m)	$0.00*	-$946.26K*	(m)	$236.94K	(m)	$0.00
2012-03-31	Reported	(m)	-$899.86K	(m)	(m)	(m)	$0.00	-$130.14K	(m)	$363.61K	(m)	$0.00
2011-09-30	Reported	(m)	-$2.60M	(m)	(m)	(m)	$0.00*	-$1.85M*	(m)	$1.72M	(m)	$0.00
2011-06-30	Reported	(m)	-$2.48M	(m)	(m)	(m)	(m)	-$1.82M*	(m)	$1.58M	(m)	$0.00
2011-03-31	Reported	(m)	-$2.01M	(m)	(m)	(m)	(m)	-$1.72M	(m)	$1.18M	(m)	(m)
2010-09-30	Reported	(m)	-$1.40M	(m)	(m)	(m)	$3.56K*	-$1.06M*	(m)	$760.53K	(m)	(m)
2010-06-30	Reported	(m)	-$1.18M	(m)	(m)	(m)	(m)	(m)	(m)	$560.69K	(m)	$0.00

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	$150.14M	(m)	(m)	(m)	$2.26M	$175.05M	(m)	$19.33M	(m)	-$13.04M
2024-12-31	Reported	(m)	-$22.36M	(m)	(m)	(m)	$116.00K	-$50.62M	(m)	$3.94M	(m)	-$1.40M
2023-12-31	Reported	(m)	-$48.96M	(m)	(m)	(m)	$327.30K	-$38.41M	(m)	$13.16M	$35.80M	(m)
2022-12-31	Reported	(m)	-$30.62M	(m)	(m)	(m)	$219.36K	-$24.36M	(m)	$10.68M	$20.01M	-$585.62K
2021-12-31	Reported	(m)	-$29.44M	(m)	(m)	(m)	$1.43M	-$21.16M	(m)	$13.13M	$16.35M	-$1.25M
2020-12-31	Reported	(m)	-$27.22M	(m)	(m)	(m)	$112.64K	-$21.97M	(m)	$13.38M	$13.88M	-$5.17M
2019-12-31	Reported	(m)	-$21.01M	(m)	(m)	(m)	$36.57K	-$15.05M	(m)	$11.05M	$9.87M	-$5.06M
2018-12-31	Reported	(m)	-$26.86M	(m)	(m)	(m)	$48.89K	-$23.70M	(m)	$18.82M	$8.07M	(m)
2017-12-31	Reported	(m)	-$32.92M	(m)	(m)	(m)	$151.99K	-$28.59M	(m)	$24.49M	(m)	(m)
2017-09-30	Rolling	(m)	-$22.66M*	(m)	(m)	(m)	(m)	(m)	(m)	$16.03M*	(m)	(m)
2017-06-30	Rolling	(m)	-$23.81M*	(m)	(m)	(m)	(m)	(m)	(m)	$16.86M*	(m)	(m)
2017-03-31	Rolling	(m)	-$21.70M*	(m)	(m)	(m)	(m)	(m)	(m)	$14.54M*	(m)	(m)
2016-12-31	Reported	(m)	-$24.76M	(m)	(m)	(m)	$58.72K	-$22.27M	(m)	$15.74M	(m)	(m)
2016-12-31	Rolling	(m)	-$18.23M*	(m)	(m)	(m)	(m)	(m)	(m)	$11.71M*	(m)	(m)
2016-09-30	Rolling	(m)	-$18.22M*	(m)	(m)	(m)	(m)	(m)	(m)	$11.70M*	(m)	(m)
2016-06-30	Rolling	(m)	-$9.07M*	(m)	(m)	(m)	(m)	(m)	(m)	$4.87M*	(m)	(m)
2016-03-31	Rolling	(m)	-$4.16M*	(m)	(m)	(m)	(m)	(m)	(m)	$2.09M*	(m)	(m)
2015-12-31	Reported	(m)	-$16.65M	(m)	(m)	(m)	$15.45K	-$12.53M	(m)	$6.28M	(m)	(m)
2015-12-31	Rolling	(m)	-$16.65K*	(m)	(m)	(m)	(m)	(m)	(m)	$6.28K*	(m)	(m)
2014-12-31	Reported	(m)	-$8.90M	(m)	(m)	(m)	$25.40K	-$6.32M	(m)	$1.32M	(m)	(m)
2013-12-31	Reported	(m)	-$4.92M	(m)	(m)	(m)	$35.68K	-$3.62M	(m)	$1.23M	(m)	$0.00
2012-12-31	Reported	(m)	-$3.00M	(m)	(m)	(m)	$0.00	-$2.28M	(m)	$1.14M	(m)	$0.00
2011-12-31	Reported	(m)	-$7.21M	(m)	(m)	(m)	$1.63K	-$6.30M	(m)	$4.06M	(m)	-$493.86K
2010-12-31	Reported	(m)	-$8.51M	(m)	(m)	(m)	$10.36K	-$3.67M	(m)	$5.49M	(m)	-$280.92K

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Aquestive Therapeutics, Inc. (AQST)	United States	$0.606B	-6.67
IMPACT BIOMEDICAL INC. (IBO)	United States	$0.611B	66.47
CytomX Therapeutics, Inc. (CTMX)	United States	$0.598B	-10.25
Monopar Therapeutics (MNPR)	United States	$0.598B	-34.82
Altimmune, Inc. (ALT)	United States	$0.593B	-6.43
Neurogene Inc. (NGNE)		$0.625B	-4.46
Shattuck Labs, Inc. (STTK)	United States	$0.634B	-13.30
Phathom Pharmaceuticals, Inc. (PHAT)	United States	$0.572B	-8.76
BlossomHill Therapeutics, Inc. (BLSM)	United States	$0.647B
ZEVRA THERAPEUTICS, INC. (ZVRA)	United States	$0.668B	14.61